CLINICAL AND NEUROLOGICAL FACTORS IN THE FORMATION OF INDIVIDUAL PREDISPOSITION TO COVID-ASSOCIATED ISCHEMIC STROKE
Keywords:
COVID-19, coronavirus patients, cerebrovascular accident, atherothrombosis, anticoagulantsAbstract
Stroke is currently the leading cause of disability and one of the leading causes of death in the world. Among patients who survived after a stroke, movement disorders are observed by the end of the acute period of stroke in 85% of patients, by the end of the first year - in 70%, speech disorders (aphasia) by the end of the acute period - in 36%, by the end of the first year - in 18% of patients Ischemic stroke accounts for 60% to 80% of all reported cases
References
Grabowska-Fudala B., Jaracz K., Gуrna K. Stroke incidence, case fatality and mortality--current trends and future prognosis // Przegl. Epidemiol. — 2010. — №3. — Р. 439-442.
Hassoun H.T., Malas M.B., Freischlag J.A. Secondary stroke prevention in the era of carotid stenting: update on recent trials // Arch. Surg. — 2010. — №10. — Р.928-935.
Kaste M. Every day is a world stroke day: act now, be a stroke champion and a torchbearer! // Stroke. — 2010. — №11. — Р. 2449-2250.
Аст Now. Impementation guidelines for stroke management. — 2010.
Goldstein L.B., Bushnell C.D., Adams R.J. et al. Guidelines for the primary prevention of stroke. A guideline for health¬care professionals from the American Heart Association // Stroke. — 2010.
Yarygin K.N., Kholodenko I.V., Konieva A.A. et al. Mechanisms of positive effects of transplantation of human placental mesenchymal stem cells on recovery of rats after experimental ischemic stroke // Bull. Exp. Biol. Med. — 2009. — Vol. 148. — P. 862-868.
Stadler K. Peroxynitrite-driven mechanisms in diabetes and insulin resistance — the latest advances // Curr. Med. Chem. — 2010.
Ostrovaya T.V., Cherniy V.I. Cerebroprotection in the aspect of evidence-based medicine // Medicine of emergency conditions. - 2007. - No. 2. - S. 48-53.
The use of cerebrolysin in cerebral ischemic stroke: Method. Rec. / Ed. Corresponding Member RAMS, prof. V.I.Skvortsova. - M., 2006 .-- 25 p.
Ginsberg M.D. Adventures in pathophysiology of brain ischemia: penumbra, gene expression, neuroprotection. The Thomas Willis lecture // Stroke. — 2003. — №1. — Р. 214-223.
Cherniy V.I., Elskiy V.N., Gorodnik G.A. et al. Acute cerebral insufficiency. - Donetsk: Izd. Zaslavsky A.Yu., 2008 .-- 440 p.
Shtark MB Brain-specific proteins (antigens) and neuron function. - M .: Medicine, 1989.
Kong D.F., Topol E.J., Bittl J.A. et al. Clinical outcomes of bivalirudin for ischemic heart disease // Circulation. — 1999. — №100. – Р. 2049-2053.
Akhmatova N.R., Khodjaeva D.T. et al. Clinical and neurologikal predictors of cerebrovascular disease in hypothyrosis. Journal of neurology and Neurosuargery research.
http://dx.doi.org/10.26739/2181-0982-2020-1-15.
Davronova K., Khaydarova D. Assessment of pathogenetic factors of cerebrovascular pathology in type 2 diabetes mellitus. International Journal of Innovatie Analyses and Everging Technology eISSN 27924025 |https://openaccessjournals.euVolume:1Issue:4 Pages from 132 to 135 World Scientific 2021.
Gaffarova V., Khodjiyeva D. Features of the course of febrile seizures in children. Asian journal of pharmacetical and biological research 2021.
Khodjiyeva D.T. Analysis of the prevalence of headaches among the population in Вukhara region, Academicia Aninternational Multidisciplinaryrese arcjournal (double bl ind refereed & peer reviewed journal ) 2021.
Ходжиева Д.Т., Хайдарова Д.К., Хайдаров Н.К. Биофизические основы возникновения сирингомиелии: современные воззрения //Журнал неврологии и нейрохирургических исследований. – 2020. – Т. 1. – №. 3.
Ходжиева Д.Т. Влияние нейроиммунологических показателей больных с ишемическим инсультом на развитие постинсультной деменции //Новый день в медицине. – 2019. – №. 4. – С. 100-105.
Neo Poyiadji, Gassan Shahin, Daniel Noujaim, Michael Stone, Suresh Patel, Brent Griffith. Published Online: Mar 31, 2020 https://doi. org/10.1148/radiol.2020201187 [Электронный ресурс, дата обращения 15.10.2020].
Khaydarova D.K., Khodjieva D.T., Khaydarov N.K. Magnetic Resonance Imaging of Cerebral Hemorrhagic Stroke. International Journal of Psychosocial Rehabilitation, Vol. 24, 2020. 434-438
Khodjieva D.T., Khaydarov N.K., Kazakov B.Sh., Khaydarova D.K. Clinical and neurological factors in the formation of an individual predisposition to COVID-associated ischemic stroke. European Journal of Molecular & Clinical Medicine - 2020.
Khaydarova D.K., Samadov A.U. Current issues in the development of neuroprotective therapy in ischemic stroke. Web of Scientist: International Scientific Research Journal 2021, 6-10.
Хайдарова Д.К., Насриддинова Ш.И., Ихтиярова Г.А. Психологическое влияние карантинных мер covid-19 на матерей в послеродовом периоде. Журнал неврологии и нейрохирургических исследований №2.2021. 25-28 бет.
Ходжиева Д.Т., Бобокулов Г.Д., Хайдарова Д.К. Инсульт турли шаклларида қиёсий ташхислаш мезонлари. Журнал неврологии и нейрохирургических исследований №2.2021. 31-34 бет.
Khodjieva D.T., Safarov K.K. A Study of Neuropsychological Symptomatology and Its Clinical Features in Patients with COVID-19. American Journal of Medicine and Medical Sciences 2021, 11(2): 126-129
Рахимбаева Гульнора Саттаровна, Шодиев Улуғбек Дониёр ўғли. Постковид цeрeбро-астeник синдром: диагностик йондашувларни оптималлаштириш, долзарб жихатлари // Журнал неврологии и нейрохирургических исследований №2.2021. 6-10 бет.
Туйчиев Л.Н., Рахимбаева Г.С., Газиева Ш.Р., Атаниязов М.К. Новая коронавирусная ин¬фекция и постковидные неврологиче¬ские последствия заболевания // Вестник ТМА № 2, 2021. 45-50 стр.
Атаниязов Махсуджан Камаладдинович, Рахимбаева Гульнора Саттаровна, Газиева Шохида Рустамовна. Характерные особенности инсульта при covid-19 // Журнал неврологии и нейрохирургических исследований №2.2021.14-17 стр.
